Abdyrahman Nour

Regional Finance Manager APAC & Russia at Ion Beam Applications SA

Abdyrahman Nour is an experienced finance professional currently serving as the Regional Finance Manager for APAC & Russia at IBA since June 2014, with a mission to reorganize finance capabilities and develop international teams. Responsibilities include business partnering with the VP of Asia, overseeing local accounting, compliance, controlling, tax, treasury, and corporate secretary functions. Prior roles include Business Controller Manager for PT EQ, where Abdyrahman focused on embedding controlling functions in the Proton therapy business unit, and Business & Financial Controller, managing revenue recognition and budgeting processes for 70% of IBA's business. Additional experience includes positions at Experis Belgium, Alstom Transport as a Project Controller consultant, EDF as a Business Controller Consultant, and Caterpillar Inc. as a Project Cost Analyst. Abdyrahman holds a DECF & DESCF in expertise comptable from Académie de Amiens and is pursuing a Master's degree in Finance at Université catholique de Louvain.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Ion Beam Applications SA

4 followers

Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.


Employees

1,001-5,000

Links